Get started
Author

Luke Nolan

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial
2020 · John A Bridgewater, Siân A Pugh, et al. · The Lancet Oncology · 252
PDF
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1–Deficient Malignant Pleural Mesothelioma
2016 · Peter W. Szlosarek, Jeremy P. Steele, et al. · JAMA Oncology · 202
PDF
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND—A Double-Blind, Randomized, Phase II Study
2019 · Dean A. Fennell, Paul Baas, et al. · Journal of Clinical Oncology · 132
Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC
2016 · Edurne Arriola, Matthew Wheater, et al. · Journal of Thoracic Oncology · 117
PDF
Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer
2019 · Max Hardy-Werbin, Pedro Rocha, et al. · OncoImmunology · 90
PDF
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma
2024 · Peter W. Szlosarek, Benjamin C. Creelan, et al. · JAMA Oncology · 60
PDF
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma
2024 · Min Zhang, Aleksandra Bzura, et al. · Nature Communications · 33
PDF
The clinical features and management of testicular germ cell tumours in patients aged 60 years and older
2011 · Matthew J. Wheater, James Manners, et al. · British Journal of Urology · 20
Genetic and immune landscape evolution in MMR‐ deficient colorectal cancer
2023 · Benjamin R Challoner, Andrew Woolston, et al. · The Journal of Pathology · 16
PDF
Evolutionary characterization of lung cancer metastasis
2026 · Sonya Hessey, Abigail Bunkum, et al. · Nature · 12
PDF
The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer
2010 · Luke Nolan, Angela Darby, et al. · The Breast · 12
Somatic evolution following cancer treatment in normal tissue
2025 · Oriol Pich, Sophia Ward, et al. · Nature · 11
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study
2024 · Laura Moliner, Núria Zellweger, et al. · JTO Clinical and Research Reports · 10
PDF
CD8 T‐cell‐mediated cerebellitis directed against Purkinje cell antigen after ipilimumab for small cell lung cancer
2021 · Marc Hardwick, Luke Nolan, et al. · Neuropathology and Applied Neurobiology · 10
PDF
ATOMIC-Meso: A randomized phase 2/3 trial of ADI-PEG20 or placebo with pemetrexed and cisplatin in patients with argininosuccinate synthetase 1-deficient non-epithelioid mesothelioma.
2017 · Peter Wojciech Szlosarek, Paul Baas, et al. · Journal of Clinical Oncology · 10
Randomized trial of arginine deprivation with pegylated arginine deiminase in patients with malignant pleural mesothelioma.
2014 · Peter Wojciech Szlosarek, Jeremy Peter Steele, et al. · Journal of Clinical Oncology · 9
Abstract CT007: Phase 2-3 trial of pegargiminase plus chemotherapy versus placebo plus chemotherapy in patients with non-epithelioid pleural mesothelioma
2023 · Peter W. Szlosarek, Ben Creelan, et al. · Cancer Research · 8
Late relapse (>2 years) on surveillance in stage I non‐seminomatous germ cell tumours; predominant seminoma only histology
2010 · Luke Nolan, Matthew Wheater, et al. · British Journal of Urology · 7
Bemcentinib and pembrolizumab in patients with relapsed mesothelioma: MIST3, a phase IIa trial with cellular and molecular correlates of efficacy.
2023 · Matthew G Krebs, Amy Branson, et al. · Journal of Clinical Oncology · 6
PDF
A Phase I Clinical Trial of Irinotecan and Carboplatin in Patients with Extensive Stage Small Cell Lung Cancer
2012 · Simon J. Crabb, Jennifer Bradbury, et al. · Chemotherapy · 6
CD8 T cell-mediated cerebellitis directed against Purkinje cell antigen after ipilimumab for small cell lung cancer
2021 · Marc Hardwick, Luke Nolan, et al. · Journal of the Neurological Sciences · 3
Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer
2022 · Benjamin R. Challoner, Andrew Woolston, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
46 Evaluation of Cardiology Investigations for Oncology Patients on Tyrosine Kinase Inhibitors
2026 · Srishti Agarwal, Emma Khoury, et al. · Lung Cancer
Retrospective review of patterns of recurrence in patients with a histological diagnosis of thymoma
2023 · Huili James Chong, Judith Cave, et al. · Lung Cancer
061 T cell-mediated cerebellitis after ipilimumab for small cell lung cancer
2022 · Remi Guillochon, Luke Nolan, et al. · Journal of Neurology Neurosurgery & Psychiatry
Works count: 30
Citation count: 1,028
H-index: 11
I10-index: 15
Year
Topic
Type